Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

被引:13
|
作者
Torcuator, Roy [1 ]
Zuniga, Richard [1 ]
Loutfi, Randa [2 ]
Mikkelsen, Tom [1 ,3 ]
机构
[1] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurosurg, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Med Oncol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurol, Detroit, MI 48202 USA
关键词
Brainstem; Glioma; Diffuse chemotherapy; Bevacizumab; Irinotecan; CHILDREN; CHEMOTHERAPY; RADIOTHERAPY; TRIAL;
D O I
10.1007/s11060-008-9782-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse brainstem glioma carries a dismal prognosis. The current cornerstone of treatment is radiation therapy. Chemotherapy appears to be ineffective and the role of this treatment in the recurrent or progressive setting is not known. Bevacizumab and irinotecan have been reported to have shown radiographic response and improvement in progression-free survival among patients with malignant supratentorial gliomas. In this paper, we report our experience in an adult patient with progressive diffuse brainstem glioma treated with bevacizumab and irinotecan.
引用
收藏
页码:409 / 412
页数:4
相关论文
共 50 条
  • [1] Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report
    Roy Torcuator
    Richard Zuniga
    Randa Loutfi
    Tom Mikkelsen
    Journal of Neuro-Oncology, 2009, 93 : 409 - 412
  • [2] A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features
    Moriya, Shigeta
    Ohba, Shigeo
    Adachi, Kazuhide
    Nishiyama, Yuya
    Hayashi, Takuro
    Nagahisa, Shinya
    Kaito, Takafumi
    Nakae, Shunsuke
    Hirose, Yuichi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 47 : 228 - 233
  • [3] A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
    El-Khouly, Fatma E.
    Veldhuijzen van Zanten, Sophie E. M.
    Jansen, Marc H. A.
    Bakker, Dewi P.
    Sanchez Aliaga, Esther
    Hendrikse, N. Harry
    Vandertop, W. Peter
    van Vuurden, Dannis G.
    Kaspers, Gertjan J. L.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (02) : 263 - 271
  • [4] A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
    Fatma E. El-Khouly
    Sophie E. M. Veldhuijzen van Zanten
    Marc H. A. Jansen
    Dewi P. Bakker
    Esther Sanchez Aliaga
    N. Harry Hendrikse
    W. Peter Vandertop
    Dannis G. van Vuurden
    Gertjan J. L. Kaspers
    Journal of Neuro-Oncology, 2021, 153 : 263 - 271
  • [5] Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours
    Poulsen, Hans Skovgaard
    Grunnet, Kirsten
    Sorensen, Morten
    Olsen, Preben
    Hasselbalch, Benedikte
    Nelausen, Knud
    Kosteljanetz, Michael
    Lassen, Ulrik
    ACTA ONCOLOGICA, 2009, 48 (01) : 52 - 58
  • [6] Brainstem Glioma: Case Report
    Herrera Anibal, Vargas
    Romero Flavio, Ramalho
    Castillejos Ali, Diaz
    Neto Feres, Chaddad
    Jose Maria, De Campos
    Oliveira Evandro, De
    REVISTA MEXICANA DE NEUROCIENCIA, 2009, 10 (06): : 479 - 483
  • [7] Pediatric brainstem abscess with hemorrhage mimicking diffuse intrinsic pontine glioma: a case report
    Kim, Ju-Hwi
    Jung, Tae-Young
    Jung, Seung-Hoon
    Lee, Kyung-Hwa
    Kim, Seul-Kee
    CHILDS NERVOUS SYSTEM, 2015, 31 (12) : 2359 - 2362
  • [8] Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan
    Toft, Anders
    Urup, Thomas
    Christensen, Ib Jarle
    Michaelsen, Signe Regner
    Lukram, Babloo
    Grunnet, Kirsten
    Kosteljanetz, Michael
    Larsen, Vibeke Andree
    Lassen, Ulrik
    Broholm, Helle
    Poulsen, Hans Skovgaard
    CANCER INVESTIGATION, 2018, 36 (02) : 165 - 174
  • [9] Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma
    Fontanilla, Hiral P.
    Pinnix, Chelsea C.
    Ketonen, Leena M.
    Woo, Shiao Y.
    Vats, Tribhawan S.
    Rytting, Michael E.
    Wolff, Johannes E.
    Mahajan, Anita
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 51 - 57
  • [10] A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden
    Sandstrom, Maria
    Laudius, Maria
    Lindqvist, Thomas
    Asklund, Thomas
    Johansson, Mikael
    ANTICANCER RESEARCH, 2017, 37 (04) : 1869 - 1874